Labour Tuesday unveiled a new life sciences sector plan that it said will create thousands of jobs and inject growth into research and development investment.The plan is designed to turbocharge pharmaceutical research and development in…
Continue Reading
What You Should Know:
ObjectiveHealth, a pioneer in integrated specialty research, today announced a strategic investment from Vitruvian Partners, a renowned global growth equity firm.
– This strategic investment will fuel ObjectiveHealth’s expansion and…
Continue Reading
What You Should Know:
– Motif Neurotech, a pioneer in minimally-invasive bioelectronics for mental health, announced today an impressive $18.75 million Series A funding round. Led by Arboretum Ventures, the investment saw participation from prominent…
Continue Reading
What You Should Know:
– Circular Genomics, a pioneer in unlocking the secrets of circular RNA (circRNA) for precision psychiatry and neurology, has secured $8.3 million in a Series A funding round. Led by Mountain…
Continue Reading
Investment trends panel discussion, INVEST 2022. From L-R: Christina Jenkins, venture partner, Phoenix Venture Partners; Michael Yang, managing partner, Omers Ventures; Alyssa Jaffee, partner, 7wireVentures; Daniel Lubienietzky, manager of life sciences, TMX Group.
The MedCity…
What You Should Know:
– Invitae (NYSE: NVTA), a medical genetics company, announced the completion of its sale of certain reproductive health assets, including carrier screening and non-invasive prenatal screening (NIPS), to Natera (NASDAQ: NTRA).
–…
Continue Reading
The landscape of healthcare and life sciences is rapidly changing, influenced by challenges from the Covid-19 pandemic. In 2024, several trends are emerging that could greatly affect the industry, said Dr. Asif Dhar, U.S….
Continue Reading
8 digital health and life sciences executives share their hot takes and insights from the recent annual JPM Healthcare Conference 2024
Virgil Bretz, co-founder and CEO of MacroHealth
“The annual JP Morgan Healthcare Conference is still…
Continue Reading
James Coutcher, Sr.Director and Global Head of Emerging Methods and Solutions for IQVIA
In today’s complex healthcare landscape, real-world data (RWD) is increasingly valued for its information regarding diverse patient populations. Clinical research sites are…
Continue Reading
Vinita Navadgi, Sr. Director, Product & Strategy, Patient Consent, IQVIA Technologies
The clinical trials landscape continues to evolve and with it, an exponential growth in the adoption of electronic informed consent (eConsent) solutions. These solutions…
Continue Reading
